| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -1,756 | -626 |
| Net decrease in cash, cash equivalents and restricted cash | -15,132 | -15,910 |
| Cash and cash equivalents at beginning of period | 17,909 | - |
| Cash and cash equivalents at end of period | 2,777 | - |
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc. (CARM)